Cita APA (7a ed.)
H, Y., K, Y., J, K., J, Y., M, T., T, S., . . . AU, B. (2005). Safety, tolerability, and pharmacokinetics of TAS-108 in normal healthy post-menopausal female subjects: A phase I study on single oral dose [corrected] [published erratum appears in J CLIN PHARM THER 2006 Apr;31(2):204]. Journal of Clinical Pharmacy & Therapeutics, 30(5), 459-471.
Cita Chicago Style (17a ed.)
H, Yamaya, Yoshida K, Kuritani J, Yonezawa J, Tsuda M, Shindo T, Nagayama S, y Buzdar AU. "Safety, Tolerability, and Pharmacokinetics of TAS-108 in Normal Healthy Post-menopausal Female Subjects: A Phase I Study on Single Oral Dose [corrected] [published Erratum Appears in J CLIN PHARM THER 2006 Apr;31(2):204]." Journal of Clinical Pharmacy & Therapeutics 30, no. 5 (2005): 459-471.
Cita MLA (9a ed.)
H, Yamaya, et al. "Safety, Tolerability, and Pharmacokinetics of TAS-108 in Normal Healthy Post-menopausal Female Subjects: A Phase I Study on Single Oral Dose [corrected] [published Erratum Appears in J CLIN PHARM THER 2006 Apr;31(2):204]." Journal of Clinical Pharmacy & Therapeutics, vol. 30, no. 5, 2005, pp. 459-471.
Precaución: Estas citas no son 100% exactas.